2014
DOI: 10.3892/ijo.2014.2617
|View full text |Cite
|
Sign up to set email alerts
|

Naringin inhibits growth and induces apoptosis by a mechanism dependent on reduced activation of NF-κB/COX-2-caspase-1 pathway in HeLa cervical cancer cells

Abstract: Naringin (NRG), a bioflavonoid found in citrus fruit extracts, has been pharmacologically evaluated as a potential anticancer agent. This study confirmed a novel mechanism of the anticancer effects of NRG in the human cervical cancer HeLa cell line (HeLa cells). Exposure of HeLa cells to NRG resulted in growth inhibition, as evidenced by a decrease in cell viability. In addition, NRG treatment induced apoptosis, as indicated by the increased apoptotic percentage and the cleaved caspase-3 expression. Importantl… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
39
0

Year Published

2015
2015
2022
2022

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 70 publications
(41 citation statements)
references
References 49 publications
(62 reference statements)
2
39
0
Order By: Relevance
“…On the other hand, caspase‐1 that cleaves pro‐IL‐1β to mature IL‐1β, is an activator of NF‐κB. Interestingly, the NF‐κB‐COX‐2/caspase‐1 pathway has been demonstrated to be responsible for cell growth, anti‐apoptosis and inflammation in CC cells . Toll‐like receptor 4 (TLR4) is a pattern recognition (or Toll‐like) receptor, which is also associated with tumor growth and inflammation in CC.…”
Section: Inflammation and CCmentioning
confidence: 99%
“…On the other hand, caspase‐1 that cleaves pro‐IL‐1β to mature IL‐1β, is an activator of NF‐κB. Interestingly, the NF‐κB‐COX‐2/caspase‐1 pathway has been demonstrated to be responsible for cell growth, anti‐apoptosis and inflammation in CC cells . Toll‐like receptor 4 (TLR4) is a pattern recognition (or Toll‐like) receptor, which is also associated with tumor growth and inflammation in CC.…”
Section: Inflammation and CCmentioning
confidence: 99%
“…Naringin (750 μM) showed an anti-proliferative effect on SiHa human cervical cancer cells through cell cycle arrest in the G2/M phase and apoptosis induction via disruption of mitochondrial transmembrane potential, and the activation of both the intrinsic and extrinsic pathways [130]. By contrast, naringin (1 mM) induced growth inhibition and apoptosis by suppressing the NF-κB/COX-2-caspase-1 pathway on HeLa cells [131]. Recently, the role of glycoconjugates in cancer cells has been a focus because of their regulatory effects on malignant phenotypes.…”
Section: Preclinical Studiesmentioning
confidence: 99%
“…Previous studies indicate that naringin suppressed cell growth of HeLa cervical cancer cells (18), human triple-negative breast cancer cells (19) and P388 cells (20). Therefore, it is hypothesized that naringin may be used as an effective anticancer agent for therapy in lung cancer.…”
Section: Discussionmentioning
confidence: 99%